Oct 16
Only a day after recommending an emergency use authorization for Moderna’s booster vaccine dose, the FDA panel of advisers is back with a similar recommendation for Johnson & Johnson’s Janssen COVID-19 vaccine. The committee unanimously voted in favor of granting J&J an emergency use authorization, though the terms under which the booster would be offered differs from the EUA granted … Continue reading
Post a Comment